Black Rock Inc. Fibrogen Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Black Rock Inc. holds 6,967,918 shares of FGEN stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,967,918
Previous 7,205,300
3.29%
Holding current value
$6.2 Million
Previous $6.41 Million
155.36%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding FGEN
# of Institutions
120Shares Held
62.2MCall Options Held
1.54MPut Options Held
221K-
Primecap Management CO Pasadena, CA14.4MShares$12.8 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY7.94MShares$7.06 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$5.73 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.5MShares$2.23 Million0.02% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ2.21MShares$1.96 Million0.02% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $83.4M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...